IL-17A in Human Respiratory Diseases: Innate or Adaptive Immunity? Clinical Implications
Figure 2
Sputum IL-17A mRNA levels in CF patients without and with ABPA. Sputum mRNA was extracted from adult CF patients without () and with () ABPA and IL-17A mRNA levels were measured by real-time RT-PCR [44]. ABPA was defined on the basis of (1) deteriorating lung function, (2) immediate Aspergillus fumigatus () skin test reactivity, (3) serum total IU/mL, (4) elevated specific IgE and IgG antibodies, and (5) chest radiographic infiltrates. * by Mann-Withney test.
